SR

Seth Rudnick

Chairman at Liquidia Technologies

Norwalk, Connecticut

Overview

Work Experience

Liquidia Technologies

  • Chairman

    2008 - Current

CP

Canaan Partners

  • Retired Partner

    1998 - 2013

Cytotherapeutics

  • CEO and Chairman

    1991 - 1998

OB

Ortho Biotech

  • Executive VP R&D

    1986 - 1991

Biogen, Inc.

  • Senior Vice President Pharmaceutical Development

    1981 - 1986

Education

Investments

VaxInnate

Series C

Total Funding: $70M

CombinatoRx

Series C

Total Funding: $30M

Amicas

Post Ipo Equity

Total Funding: $9M

Relevant Websites